Australia has witnessed a significant increase in ADHD prescriptions, with a 25% year-over-year rise in 2025. This surge has prompted concerns among doctors and regulators regarding the role of telehealth in diagnosing ADHD and the potential impact on the National Disability Insurance Scheme (NDIS).
The number of Australians taking ADHD medications has reached nearly 1 million, with 837,937 patients receiving 6.7 million scripts in 2025. This trend has raised questions about the accuracy of telehealth diagnoses and the potential consequences for the NDIS.
The increase in ADHD prescriptions has led to scrutiny of telehealth diagnoses, with some experts expressing concerns about the potential for misdiagnosis or overdiagnosis. The Australian government has announced plans to review the use of telehealth in ADHD diagnoses.
The rise in ADHD prescriptions is a wake-up call for us to re-examine our approach to diagnosis and treatment.
"The rise in ADHD prescriptions has also sparked concerns about the potential cost impacts on the NDIS. The scheme provides funding for Australians with disabilities, and the increasing number of ADHD diagnoses could put a strain on resources.
ADHD Prescription Rise: 25% year-over-year increase in ADHD prescriptions in Australia.
Telehealth Diagnoses: Scrutiny over the accuracy of telehealth diagnoses.
NDIS Cost Impacts: Potential strain on NDIS resources due to increasing ADHD diagnoses.
As the Australian government reviews the use of telehealth in ADHD diagnoses, it is essential to consider the potential consequences for the NDIS and the impact on individuals and families affected by ADHD. By understanding the complexities of ADHD and its diagnosis, we can work towards creating a more effective and sustainable support system.
By understanding the complexities of ADHD and its diagnosis, we can work towards creating a more effective and sustainable support system. The Learning Success All Access Program offers a free trial that includes a personalized Action Plan, empowering parents to take control of their child’s learning journey.
